MDxHealth SA MDXH

Set alert

Price alert · MDXH

All alert types
0.16 USD -0.01 -3.86%

At close · Nov 2

0.17 +0.01 +5.73%

After hours · Nov 2, 4:00 PM ET

Bid
0.16 × 6
Ask
0.16 × 1
0.1553 Day range 0.1695
0.1553 52-week range 4.93
YTD
-95.60%
1 year
-96.81%
Open
0.165
Prev close
0.1633
Mkt cap
14.98M
Vol
812.71K
Avg vol
6.20M
EPS
-0.71
P/E
0.00
Div yield
0.00%
More statistics
Low
0.1553
High
0.1695
Forward P/E
-3.81
Beta
-393982.88
Short ratio
0.22
Inst. own
48.66%
Dividend
0.00
Ex-div date
Earnings
Nov 8, 2023
50-d avg
2.02
200-d avg
2.50
1y target
6.04

5D chart

Chart tools
Interval

Signals (120)
NameTimeAgo
SMA: BullishOct 30, 4:00 PM3 days ago
MACD: Sell SignalOct 30, 3:25 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
SMA: BullishOct 30, 3:10 PM3 days ago
SMA: BullishOct 30, 3:10 PM3 days ago
SMA: BearishOct 30, 2:50 PM3 days ago
SMA: BearishOct 30, 2:50 PM3 days ago
SMA: BullishOct 30, 2:30 PM3 days ago
SMA: BullishOct 30, 2:30 PM3 days ago
SMA: BearishOct 30, 2:05 PM3 days ago
SMA: BearishOct 30, 11:55 AM3 days ago
MACD: Buy SignalOct 30, 11:35 AM3 days ago
SMA: BullishOct 30, 11:20 AM3 days ago
SMA: BearishOct 30, 11:10 AM3 days ago
SMA: BullishOct 30, 11:05 AM3 days ago
RSI: OversoldOct 30, 10:45 AM3 days ago
RSI: OversoldOct 30, 10:10 AM3 days ago
SMA: BearishOct 30, 9:50 AM3 days ago
MACD: Sell SignalOct 30, 9:50 AM3 days ago
SMA: BearishOct 30, 9:35 AM3 days ago
RSI: OverboughtOct 30, 9:30 AM3 days ago
SMA: BullishOct 29, 2:35 PM4 days ago
SMA: BullishOct 29, 2:25 PM4 days ago
SMA: BearishOct 29, 2:20 PM4 days ago
SMA: BearishOct 29, 2:15 PM4 days ago
SMA: BullishOct 29, 2:10 PM4 days ago
SMA: BullishOct 29, 1:40 PM4 days ago
SMA: BearishOct 29, 1:05 PM4 days ago
SMA: BullishOct 29, 12:55 PM4 days ago
MACD: Buy SignalOct 29, 12:55 PM4 days ago
SMA: BearishOct 29, 12:45 PM4 days ago
SMA: BullishOct 29, 12:40 PM4 days ago
MACD: Sell SignalOct 29, 11:30 AM4 days ago
SMA: BearishOct 29, 11:20 AM4 days ago
SMA: BearishOct 29, 11:20 AM4 days ago
MACD: Buy SignalOct 29, 11:10 AM4 days ago
SMA: BullishOct 29, 11:05 AM4 days ago
SMA: BullishOct 29, 10:55 AM4 days ago
SMA: BearishOct 29, 10:05 AM4 days ago
SMA: BearishOct 29, 10:05 AM4 days ago
SMA: BullishOct 29, 10:00 AM4 days ago
SMA: BullishOct 29, 9:50 AM4 days ago
SMA: BearishOct 29, 9:35 AM4 days ago
SMA: BearishOct 29, 9:35 AM4 days ago
MACD: Sell SignalOct 29, 9:35 AM4 days ago
SMA: BullishOct 28, 3:55 PM5 days ago
SMA: BearishOct 28, 3:50 PM5 days ago
SMA: BullishOct 28, 3:45 PM5 days ago
SMA: BearishOct 28, 3:40 PM5 days ago
SMA: BullishOct 28, 2:20 PM5 days ago
SMA: BearishOct 28, 1:40 PM5 days ago
SMA: BullishOct 28, 12:40 PM5 days ago
SMA: BullishOct 28, 12:40 PM5 days ago
SMA: BearishOct 28, 12:35 PM5 days ago
SMA: BullishOct 28, 12:30 PM5 days ago
SMA: BearishOct 28, 12:20 PM5 days ago
SMA: BearishOct 28, 12:10 PM5 days ago
SMA: BullishOct 28, 11:55 AM5 days ago
SMA: BullishOct 28, 11:50 AM5 days ago
SMA: BearishOct 28, 11:45 AM5 days ago
MACD: Buy SignalOct 28, 11:45 AM5 days ago
SMA: BullishOct 28, 11:40 AM5 days ago
SMA: BearishOct 28, 11:25 AM5 days ago
SMA: BullishOct 28, 11:15 AM5 days ago
SMA: BearishOct 28, 9:45 AM5 days ago
SMA: BearishOct 28, 9:45 AM5 days ago
MACD: Sell SignalOct 28, 9:45 AM5 days ago
SMA: BullishOct 28, 9:35 AM5 days ago
SMA: BullishOct 28, 9:35 AM5 days ago
MACD: Buy SignalOct 28, 9:35 AM5 days ago
SMA: BearishOct 27, 3:55 PM6 days ago
MACD: Sell SignalOct 27, 3:55 PM6 days ago
SMA: BearishOct 27, 3:50 PM6 days ago
SMA: BullishOct 27, 3:40 PM6 days ago
MACD: Buy SignalOct 27, 3:40 PM6 days ago
SMA: BearishOct 27, 3:35 PM6 days ago
MACD: Sell SignalOct 27, 3:35 PM6 days ago
MACD: Buy SignalOct 27, 3:15 PM6 days ago
SMA: BullishOct 27, 3:05 PM6 days ago
SMA: BearishOct 27, 2:40 PM6 days ago
MACD: Sell SignalOct 27, 2:40 PM6 days ago
SMA: BullishOct 27, 2:35 PM6 days ago
SMA: BearishOct 27, 2:30 PM6 days ago
SMA: BullishOct 27, 2:10 PM6 days ago
MACD: Buy SignalOct 27, 2:10 PM6 days ago
MACD: Sell SignalOct 27, 2:00 PM6 days ago
SMA: BearishOct 27, 1:50 PM6 days ago
SMA: BullishOct 27, 12:40 PM6 days ago
MACD: Buy SignalOct 27, 12:40 PM6 days ago
MACD: Sell SignalOct 27, 12:30 PM6 days ago
SMA: BearishOct 27, 12:20 PM6 days ago
SMA: BullishOct 27, 11:50 AM6 days ago
SMA: BullishOct 27, 11:50 AM6 days ago
MACD: Buy SignalOct 27, 11:30 AM6 days ago
SMA: BearishOct 27, 11:20 AM6 days ago
SMA: BullishOct 27, 11:15 AM6 days ago
SMA: BullishOct 27, 10:50 AM6 days ago
SMA: BearishOct 27, 10:35 AM6 days ago
SMA: BullishOct 27, 10:30 AM6 days ago
MACD: Sell SignalOct 27, 10:20 AM6 days ago
SMA: BearishOct 27, 10:15 AM6 days ago
SMA: BullishOct 27, 9:40 AM6 days ago
SMA: BullishOct 27, 9:40 AM6 days ago
SMA: BearishOct 27, 9:30 AM6 days ago
SMA: BearishOct 27, 9:30 AM6 days ago
SMA: BullishOct 26, 3:55 PM1 week ago
MACD: Buy SignalOct 26, 3:55 PM1 week ago
MACD: Sell SignalOct 26, 3:50 PM1 week ago
SMA: BearishOct 26, 3:45 PM1 week ago
MACD: Buy SignalOct 26, 3:05 PM1 week ago
SMA: BullishOct 26, 2:50 PM1 week ago
SMA: BullishOct 26, 2:50 PM1 week ago
SMA: BearishOct 26, 2:30 PM1 week ago
MACD: Sell SignalOct 26, 2:00 PM1 week ago
SMA: BullishOct 26, 12:15 PM1 week ago
SMA: BearishOct 26, 11:50 AM1 week ago
SMA: BullishOct 26, 11:45 AM1 week ago
SMA: BearishOct 26, 11:10 AM1 week ago
SMA: BullishOct 26, 10:55 AM1 week ago

Key statistics

Market cap
107.41M
Enterprise value
69.28M
Trailing P/E
0.00
Forward P/E
-3.81
PEG ratio
0.00
Price / sales
1.27
Price / book
3.57
EPS (TTM)
-1.53
Beta
-393982.88
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-49.52%
Revenue (TTM)
84.71M
Revenue growth
20.50%
Free cash flow
5.11M
Total cash
49.27M
Total debt
55.34M
Return on equity
-240.82%
Shares outstanding
49.50M
Short % of float
0.10%
50-day average
2.02
200-day average
2.50

Analyst view

Consensus: none

Price target (mean) 6.04 +3747.1% upside
Target (low)
4.20
Target (mean)
6.04
Target (high)
7.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Nov 8, 2023

Expected Nov 8, 2023. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
MDXH Revenue — quarterly 23.72M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
MDXH Net income — quarterly -11.53M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
MDXH EPS — quarterly -2.30
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

MDXH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 6, 2024Sep 1, 2024-0.27-0.40-0.13-48.15%
Aug 21, 2024Jun 1, 2024-0.26-0.31-0.05-19.23%
May 1, 2024Mar 1, 2024-0.30-0.31-0.01-3.33%
Mar 6, 2024Dec 1, 20230.00-0.39——
Nov 8, 2023Sep 1, 2023-0.31———
Aug 23, 2023Jun 1, 2023-0.32———

Upgrades / downgrades

MDXH analyst upgrades and downgrades
DateFirmActionFromTo
Nov 7, 2024Piper SandlermainOverweightOverweight
Oct 31, 2024Lake Streetinit—Buy
Mar 7, 2024Piper SandlermainOverweightOverweight
Mar 7, 2024BTIGmainBuyBuy

About MDxHealth SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Sector
Healthcare
Industry
Diagnostics & Research
Country
Belgium

News

Your note

Sign in to keep a note on MDXH — it syncs with the Stock Master app.

Insider holders

MDXH insider holders
InsiderRelationLatest transactionDateShares held
MVM PARTNERS LLPBeneficial Owner of more than 10% of a Class of SecurityPurchaseFeb 2, 20230

Institution ownership

MDXH institution ownership
Holder% heldSharesValueReported
Bleichroeder LP30.70%8,378,33318.18MSep 29, 2024
MVM Partners, LLC17.23%4,700,45710.20MSep 29, 2024
AWM Investment Company, Inc.15.57%4,250,0009.22MSep 29, 2024
Soleus Capital Management, L.P.4.05%1,105,0002.40MSep 29, 2024
Alyeska Investment Group, L.p.3.69%1,007,0002.19MSep 29, 2024
Monashee Investment Management LLC3.66%1,000,0002.17MSep 29, 2024

Fund ownership

MDXH fund ownership
Holder% heldSharesValueReported
World Funds Tr-Perkins Discovery Fund0.13%35,00075.95KSep 29, 2024
Fidelity NASDAQ Composite Index Fund0.02%5,26311.42KOct 30, 2024
Brighthouse Fds Tr II-BH/Dimensional International Small Co Port0.00%8431.83KSep 29, 2024